Michael Berend, MD
Orthopaedic Surgery · Indianapolis, INNPI 1790761666
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $4,025,255 of the $4,027,403 with a category attached, or 99.9%. Zimmer Biomet accounts for 100.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $2,275,868 and has fallen 100.0% since, to $155 in 2025. Among orthopaedic surgery clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 55 payments — averaging $73,226 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$4M
- Medacta USA, Inc.$1K
- Engage Uni, LLC$114
- Avanos Medical$99
- Crossroads Orthopedics, LLC$67
- Total Joint Orthopedics, Inc.$56
- plus $92 from 3 others
Across 21 payments — averaging $1798.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Zimmer Biomet$38K
What the payments were for
- Royalty or licence$4,025,255100%
- Travel & lodging$6710%
- Food & beverage$1,3630%
- Gifts$1140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 40 | $4,025,878 |
| Medacta USA, Inc. | 7 | $1,098 |
| Engage Uni, LLC | 1 | $114 |
| Avanos Medical | 1 | $99 |
| Crossroads Orthopedics, LLC | 2 | $67 |
| Total Joint Orthopedics, Inc. | 1 | $56 |
| Stryker | 1 | $52 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Dynasplint Systems Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Oxford-Knees$3,100,841
- Arcos$2,348,030
- Persona$1,677,225
- Trabecular Metal (TM)$1,677,225
- Taperloc$1,677,225
- Vanguard$1,677,225
- Oxford$924,414
- GMK Sphere Revision System$577
- GMK SPHERE$140
- Knees-None$116
- Hips-None$116
- Engage Partial Knee System$114
How this compares
$4,027,403 in reported general payments places this provider in the 95th percentile of 400 orthopaedic surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 36 | $1,912 |
| Tranexamic Acid | 104 | $510 |
| Cephalexin | 32 | $348 |
| Meloxicam | 87 | $294 |
| Hydroxyzine Hcl | 13 | $207 |
| Methylprednisolone | 26 | $154 |
| Amoxicillin | 43 | $55 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Indianapolis
- David FisherIndianapolis$5.9M
- Sanford KunkelIndianapolis$1.9M
- Hill HastingsIndianapolis$1.6M
- Michael CrossIndianapolis$870K
- Brian MullisIndianapolis$632K
- Dean MaarIndianapolis$589K
- Russell SwannIndianapolis$135K
- Thomas FischerIndianapolis$117K
- Wesley LackeyIndianapolis$115K
- Mark DillonIndianapolis$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.